Elutia Inc. Class A Common Stock

ELUT XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

46M

Short interest (May 15)

0.3%

Net Short (Jun 03 ): 0.0%

Borrow Fee

4.04%

↓ 3.9%

Available Shares

↑ 2.1%

Price Chart

Company Overview

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001708527

Asset Type: CS

Market Data

Market Cap: $45,976,565

Employees: 26

Status: Active

Short Interest

Current Borrow Fee 4.04%

Range: 4.04% - 4.06%

Available Shares 2M

Range: 1.6M - 1.7M

Recent Changes

Fee Change: ↓ 2.0%

Available Change: ↑ 6.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime